Application 207916
- Type
- NDA
- Sponsor
- ARBOR PHARMS LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CETYLEV | ACETYLCYSTEINE | TABLET, EFFERVESCENT;ORAL | 500MG | Yes | No |
| 002 | CETYLEV | ACETYLCYSTEINE | TABLET, EFFERVESCENT;ORAL | 2.5GM | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N207916-001 | CETYLEV | ACETYLCYSTEINE | 500MG | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | |
| N207916-002 | CETYLEV | ACETYLCYSTEINE | 2.5GM | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N207916-001 | 8747894 | 2032-05-08 | U-1373 | Drug product | 2016-02-08 |
| N207916-001 | 9427421 | 2032-05-08 | Drug product | 2016-09-23 | |
| N207916-001 | 9561204 | 2032-05-08 | U-1373 | 2017-03-09 | |
| N207916-002 | 8747894 | 2032-05-08 | U-1373 | Drug product | 2016-02-08 |
| N207916-002 | 9427421 | 2032-05-08 | Drug product | 2016-09-23 | |
| N207916-002 | 9561204 | 2032-05-08 | U-1373 | 2017-03-09 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N207916-001 | CETYLEV | 500MG | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207916-002 | CETYLEV | 2.5GM | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207916-001 | CETYLEV | 500MG | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207916-002 | CETYLEV | 2.5GM | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207916-001 | CETYLEV | 500MG | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207916-002 | CETYLEV | 2.5GM | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207916-001 | CETYLEV | 500MG | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207916-002 | CETYLEV | 2.5GM | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N207916-001 | CETYLEV | 500MG | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N207916-002 | CETYLEV | 2.5GM | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N207916-001 | CETYLEV | 500MG | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N207916-002 | CETYLEV | 2.5GM | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N207916-001 | CETYLEV | 500MG | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N207916-002 | CETYLEV | 2.5GM | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N207916-001 | CETYLEV | 500MG | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N207916-002 | CETYLEV | 2.5GM | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N207916-001 | CETYLEV | 500MG | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N207916-002 | CETYLEV | 2.5GM | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N207916-001 | CETYLEV | 500MG | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N207916-002 | CETYLEV | 2.5GM | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N207916-001 | CETYLEV | 500MG | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N207916-002 | CETYLEV | 2.5GM | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N207916-001 | CETYLEV | 500MG | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N207916-002 | CETYLEV | 2.5GM | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N207916-001 | CETYLEV | 500MG | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N207916-002 | CETYLEV | 2.5GM | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N207916-001 | CETYLEV | 500MG | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N207916-002 | CETYLEV | 2.5GM | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N207916-001 | CETYLEV | 500MG | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N207916-002 | CETYLEV | 2.5GM | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N207916-001 | CETYLEV | 500MG | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N207916-002 | CETYLEV | 2.5GM | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N207916-001 | CETYLEV | 500MG | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N207916-002 | CETYLEV | 2.5GM | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N207916-001 | CETYLEV | 500MG | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N207916-002 | CETYLEV | 2.5GM | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N207916-001 | CETYLEV | 500MG | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N207916-002 | CETYLEV | 2.5GM | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N207916-001 | CETYLEV | 500MG | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N207916-002 | CETYLEV | 2.5GM | TABLET, EFFERVESCENT / ORAL | RLD | 2016-01-29 | 782e0a99824c… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N207916-001 | 8747894 | 2032-05-08 | U-1373 | Drug product | 2016-02-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N207916-001 | 9427421 | 2032-05-08 | Drug product | 2016-09-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207916-001 | 9561204 | 2032-05-08 | U-1373 | 2017-03-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207916-002 | 8747894 | 2032-05-08 | U-1373 | Drug product | 2016-02-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N207916-002 | 9427421 | 2032-05-08 | Drug product | 2016-09-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207916-002 | 9561204 | 2032-05-08 | U-1373 | 2017-03-09 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207916-001 | 8747894 | 2032-05-08 | U-1373 | Drug product | 2016-02-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207916-001 | 9427421 | 2032-05-08 | Drug product | 2016-09-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207916-001 | 9561204 | 2032-05-08 | U-1373 | 2017-03-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207916-002 | 8747894 | 2032-05-08 | U-1373 | Drug product | 2016-02-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207916-002 | 9427421 | 2032-05-08 | Drug product | 2016-09-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207916-002 | 9561204 | 2032-05-08 | U-1373 | 2017-03-09 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207916-001 | 8747894 | 2032-05-08 | U-1373 | Drug product | 2016-02-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N207916-001 | 9427421 | 2032-05-08 | Drug product | 2016-09-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207916-001 | 9561204 | 2032-05-08 | U-1373 | 2017-03-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207916-002 | 8747894 | 2032-05-08 | U-1373 | Drug product | 2016-02-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N207916-002 | 9427421 | 2032-05-08 | Drug product | 2016-09-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207916-002 | 9561204 | 2032-05-08 | U-1373 | 2017-03-09 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207916-001 | 8747894 | 2032-05-08 | U-1373 | Drug product | 2016-02-08 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207916-001 | 9427421 | 2032-05-08 | Drug product | 2016-09-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207916-001 | 9561204 | 2032-05-08 | U-1373 | 2017-03-09 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207916-002 | 8747894 | 2032-05-08 | U-1373 | Drug product | 2016-02-08 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207916-002 | 9427421 | 2032-05-08 | Drug product | 2016-09-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207916-002 | 9561204 | 2032-05-08 | U-1373 | 2017-03-09 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N207916-001 | 8747894 | 2032-05-08 | U-1373 | Drug product | 2016-02-08 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N207916-001 | 9427421 | 2032-05-08 | Drug product | 2016-09-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N207916-001 | 9561204 | 2032-05-08 | U-1373 | 2017-03-09 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N207916-002 | 8747894 | 2032-05-08 | U-1373 | Drug product | 2016-02-08 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N207916-002 | 9427421 | 2032-05-08 | Drug product | 2016-09-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N207916-002 | 9561204 | 2032-05-08 | U-1373 | 2017-03-09 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N207916-001 | 8747894 | 2032-05-08 | U-1373 | Drug product | 2016-02-08 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N207916-001 | 9427421 | 2032-05-08 | Drug product | 2016-09-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N207916-001 | 9561204 | 2032-05-08 | U-1373 | 2017-03-09 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N207916-002 | 8747894 | 2032-05-08 | U-1373 | Drug product | 2016-02-08 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N207916-002 | 9427421 | 2032-05-08 | Drug product | 2016-09-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N207916-002 | 9561204 | 2032-05-08 | U-1373 | 2017-03-09 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N207916-001 | 8747894 | 2032-05-08 | U-1373 | Drug product | 2016-02-08 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N207916-001 | 9427421 | 2032-05-08 | Drug product | 2016-09-23 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N207916-001 | 9561204 | 2032-05-08 | U-1373 | 2017-03-09 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N207916-002 | 8747894 | 2032-05-08 | U-1373 | Drug product | 2016-02-08 | 2680178bc6a6… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetylcysteine | ACETYLCYSTEINE | Hospira, Inc. | 5558a5f5-e821-473b-7d8a-5d33d09f0586 | 2026-05-22 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Glenmark Pharmaceuticals Inc., USA | f811ddfc-d7c1-4637-ae81-80c38a77cb80 | 2026-05-06 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Somerset Therapeutics, LLC | d50c8ab6-26f8-4669-89d1-c4d26698159a | 2026-04-11 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Cardinal Health 107, LLC | c90fca12-12fb-4cf6-bd6f-83bc0d95df81 | 2026-04-07 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Eugia US LLC | 5ae53725-1abb-4122-9c85-f26c2c31566c | 2025-12-02 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Sagent Pharmaceuticals | c206c659-16ea-444a-8c60-8a3343400ada | 2025-10-26 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | ONESOURCE SPECIALTY PHARMA LIMITED | 3b0310d2-4e70-4b94-8d69-cb5999a32b54 | 2025-09-12 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Hikma Pharmaceuticals USA Inc. | 277963a0-8ab2-4305-a688-28e47e87c584 | 2025-09-09 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Cameron Pharmaceuticals | 8165ad85-98e7-438f-9567-5cfda88d0ebf | 2025-08-26 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| acetylcysteine | ACETYLCYSTEINE | Padagis US LLC | 9d305722-e74f-4f48-8d2c-0daa99144749 | 2025-07-31 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| ACETADOTE | ACETYLCYSTEINE | Cumberland Pharmaceuticals Inc. | 472f158a-5ab9-4308-8e49-1116e6ea3d39 | 2025-04-30 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | American Regent, Inc. | f56b4087-db48-4fd7-84ec-9c927962b805 | 2024-12-17 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Fresenius Kabi USA, LLC | 75b48fab-cef6-465c-a1e0-d085b3988bc4 | 2024-08-15 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Somerset Therapeutics, LLC | b8d3ed96-d7ee-43f4-986c-a7d04808711a | 2024-06-13 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Xellia Pharmaceuticals USA LLC | 3e2e187e-2445-43b1-b66c-b828e2adf022 | 2023-05-31 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Fresenius Kabi USA, LLC | 8cca4e4c-85a2-d575-e053-2995a90a6599 | 2022-10-31 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Fresenius Kabi USA, LLC | d990ef51-ced2-4359-b99b-092334d2dc9b | 2022-10-31 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Fresenius Kabi USA, LLC | 8d81039e-20ef-5144-e053-2a95a90a89fd | 2022-10-31 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Sagent Pharmaceuticals | 2324d60b-4f49-4759-a46e-a06bfce7e8aa | 2022-04-05 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| ACETYLCYSTEINE | ACETYLCYSTEINE | Indoco Remedies Limited | 6588c28d-0515-4cdf-99d3-c4ad3fd0976c | 2022-03-01 | Warnings, Adverse reactions | ACETYLCYSTEINE |